Tus kws kho mob
QP65-24 PCA Agency Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 851 - 860 ntawm 4269
Tus kws kho mob
QP66-24 Reminder: Patient Complaint Policy and Process Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024
Tus kws kho mob
QP62-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2024
Tus kws kho mob
QP64-24 MHCP Pharmacy Benefit Exclusion for Rytelo™
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2024
Tus kws kho mob
QP63-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2024
Tus kws kho mob
P49-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Radiation Oncology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P50-24 New Medical, Medical Drug and Behavioral Health Policy Management Updates, Effective October 7, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P52-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P53-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
2024 August Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024